Chorionic Gonadotropin: Clinical Trials

28 trials of Chorionic Gonadotropin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 4 unknown, 2 recruiting, 2 terminated. 28 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 328Completed 19, Unknown 4, Recruiting 2, Terminated 2, Withdrawn 1
Phase 21Completed 1

Follow Chorionic Gonadotropin: new trials by email Literature Review of Chorionic Gonadotropin trials Research Report on Chorionic Gonadotropin

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)
Human chorionic gonadotropin (hCG), Follitropin delta, Triptorelin - Low Ovarian Reserve, Poor Ovarian Response
Phase 3RecruitingFundación para la Investigación del Hospital Clínico de Valencia1262024-09-172026-09-11
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
Anastrozole, Semaglutide, human chorionic gonadotropin - Klinefelter Syndrome
Phase 3RecruitingGeorgios Papadakis1502023-03-212026-05-11
Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction
Oxytocin, Human Chorionic Gonadotropin - Ovulation Induction, Polycystic Ovary Syndrome
Phase 3CompletedShakeela Ishrat602023-01-012025-08-29
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES
10000 IU hCG (Choriomon5000 IU; IBSA), Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring) - Infertility
Phase 3UnknownAlexandria University1602022-06-012022-05-31
Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders
Duphaston, Gonadotropin, Cetrotide Injectable Product - Infertility, Female
Phase 3CompletedEl Shatby University Hospital for Obstetrics and Gynecology902020-09-012022-02-17
Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders
Dual trigger, hCG (standard) - Poor Ovarian Reserve
Phase 3CompletedAmerican University of Beirut Medical Center1402018-07-112021-07-23
Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART
hCG, Placebo - HCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin
Phase 3TerminatedNational and Kapodistrian University of Athens802018-06-012021-03-30
Triggering of Follicular Maturation
Recombinant Human Chorionic Gonadotrophin, human chorionic gonadotrophin + gonadotrophin releasing hormone agonist - Increase Pregnancy Rate
Phase 3CompletedAssiut University1602016-11-012019-03-20
Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles
hCG (Ovitrelle 250 mcg mcg - Merck Serono), hCG (Ovitrelle 250 mcg mcg - Merck Serono) + GnRH agonist (Decapeptyl 0.2mg - Ferring Gmgh) - In-vitro Fertilization
Phase 3UnknownTel-Aviv Sourasky Medical Center10002016-09-012016-08-11
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation
highly purified human chorionic gonadotropin, recombinant human chorionic gonadotropin - Infertility
Phase 3CompletedFerring Pharmaceuticals1762016-04-012019-06-26
Human Chorionic Gonadotrophin & Trigger
Human chorionic gonadotrophin, clomiphene citrate alone - Ovulation Disorder
Phase 3UnknownCairo University2002014-10-012017-02-08
Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility
Human chorionic gonadotropin, FSH co-trigger, Letrozole - Unexplained Infertility
Phase 3CompletedBenha University1082014-06-012016-05-19
An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)
MK-8962, recFSH, Ganirelix - Infertility
Phase 3WithdrawnOrganon and Co2014-03-012022-02-03
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany9392014-01-312017-08-24
Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.
Ganirelix 0.25 mg., Recombinant choriogonadotropin alfa, Micronized natural progesterone. - Infertility
Phase 3CompletedInstituto de Investigacion Sanitaria La Fe2342013-09-012017-06-12
Human Chorionic Gonadotrophin in an Antagonist Protocol
Low dose HCG, Placebo - Infertility
Phase 2 / Phase 3CompletedCairo University602013-08-012015-02-03
Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel
COL-1620, Gonadotropin-releasing hormone (GnRH) analogue, Follicle-stimulating hormone (FSH) - Luteal Hormone Supplementation in In-vitro Fertilization, Embryo Transfer
Phase 3CompletedMerck KGaA, Darmstadt, Germany1782013-07-012015-12-21
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
MSJ-0011, urinary hCG (u-hCG), Follitropin alpha - Anovulation, Oligo-ovulation
Phase 3CompletedMerck KGaA, Darmstadt, Germany812012-09-012016-01-07
A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
GONAL-f®, Luveris®, Recombinant human chorionic gonadotropin (r-hCG) - Infertility, Fertility
Phase 3TerminatedMerck KGaA, Darmstadt, Germany1742012-05-012015-11-09
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
Dexamethasone, recombinant human chorionic gonadotropin (r-hCG) - PCOS
Phase 3CompletedUniversity of California, San Diego242011-08-012019-04-30

Showing 20 of 28. Sign in to see all of them.

Conditions studied

Infertility (11)  ·  Polycystic Ovary Syndrome (4)  ·  Helping Behavior (3)  ·  Anovulation (1)  ·  Hypogonadism (1)  ·  Infertility, Female (1)  ·  Klinefelter Syndrome (1)  ·  Menstruation Disturbances (1)  ·  Metabolic Syndrome (1)  ·  Oligomenorrhea (1)

Sponsors

Merck KGaA, Darmstadt, Germany (8)  ·  Cairo University (2)  ·  Organon and Co (2)  ·  University of California, San Diego (2)  ·  Alexandria University (1)  ·  American University of Beirut Medical Center (1)  ·  Assiut University (1)  ·  Benha University (1)  ·  El Shatby University Hospital for Obstetrics and Gynecology (1)  ·  Ferring Pharmaceuticals (1)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Georgios Papadakis (1)  ·  Instituto de Investigacion Sanitaria La Fe (1)  ·  National and Kapodistrian University of Athens (1)  ·  Royan Institute (1)

Countries

Egypt (4)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Japan (2)  ·  Spain (2)  ·  United States (2)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Finland (1)  ·  Iran (1)  ·  Italy (1)

Top investigators

Ahmed Walid Anwar Murad, MD (1)  ·  Aly A Hussein, Ass.lecturer (1)  ·  Beni Almog, professor (1)  ·  Cesar Lizan Tudela (1)  ·  Charalampos Siristatidis, Ass Prof (1)  ·  Ghina S Ghazeeri, MD (1)  ·  Hamid Gourabi, PhD (1)  ·  Huafei Li (1)  ·  Mervat Sh EL-Arab, MDPhD (1)

Results publications

PMID 19684043, PMID 19719843, PMID 19825188, PMID 20843746, PMID 21270326, PMID 22866896, PMID 23274511, PMID 23543584, PMID 23758821, PMID 24188875, PMID 24903202, PMID 25303490, PMID 25313914, PMID 26141305, PMID 26194884, PMID 26950065, PMID 26991902, PMID 27473350, PMID 27619773, PMID 28137754

NIH funding

2004 (1), 2016 (1)